| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.35 | 7e-13 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.34 | 1e-10 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.26 | 5e-07 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |